Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi, UCSF in diabetes research collaboration
The $3.1m deal is believed to help gain deep insights into the insulin-producing beta cells which are destroyed in type 1 diabetes and produce little insulin in type
The $3.1m deal is believed to help gain deep insights into the insulin-producing beta cells which are destroyed in type 1 diabetes and produce little insulin in type
As per the alliance, Forma will be responsible for the discovery and development of drugs against a range of tumor metabolism targets and will be entitled to receive
Levotofisopam, the S-entantiomer of the racemic mixture RS-tofisopam, is said to be a well tolerated, effective, nonsedating agent used to treat various disorders related to stress or autonomic
Pharmacy Xpert, whicht belongs to the Clinical Xpert Suite of workflow solutions, is a clinical intelligence dashboard that aids hospital pharmacists in improving outcomes, reducing costs, and managing
The CRM solution will cater to the company’s Specialty commercial team and head office in Spain. Cegedim is also providing a healthcare professional database, OneKey and Help Desk
Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body’s T cells to kill cancer cells. As per the deal,
Gammagard Liquid is indicated as replacement therapy for primary humoral immunodeficiency in adult and pediatric patients two years of age or older. The submission of sBLA is backed
The study will compare safety and efficacy of Hospira’s EPO and the reference product, Amgen’s Epogen in patients with renal (kidney) dysfunction who have anemia. Erythropoietin is a
As per the alliance, Genentech has an exclusive license to compounds and a non-exclusive license to diagnostics from Xenon for development and commercialization of products. Xenon on the
Epanova increased EPA and DHA more than 5-Fold Compared to Lovaza After two weeks of dosing in 52 subjects on a low fat diet. Additionally, Epanova increased steady